Last reviewed · How we verify
NCT03982966: CRF
Effect of Omega 3 Fatty Acids on the Vascular Calcification Biomarkers Fetuin A and Osteoprotegerin in Patients With CRF
NA trial testing Omega 3 fatty acids (fish oil) 1000 mg/day oral in Chronic Renal Failure in 60 participants. Completed in 1 May 2020.
30 April 2020
Quick facts
| Lead sponsor | Damanhour University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 60 |
| Start date | 1 January 2019 |
| Primary completion | 30 April 2020 |
| Estimated completion | 1 May 2020 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Omega 3 fatty acids (fish oil) 1000 mg/day oral
Conditions studied
- Chronic Renal Failure — all drugs for Chronic Renal Failure →
Sponsor
Damanhour University
Who can join
Adults 20 to 80, any sex, with Chronic Renal Failure. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
study the effect of omega 3fatty acids on the vascular calcification biomarkers Fetuin -A and Osteoprotegerin (OPG) in dialysis patients.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Vascular calcification: from the perspective of crosstalk.
Yang S, Zeng Z, Yuan Q, Chen Q, et al · · 2023 · cited 13× · PMID 37851172 · DOI 10.1186/s43556-023-00146-y
Verify or expand the search:
- PubMed search for NCT03982966
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Chronic Renal Failure
Currently open trials in the same condition.
- NCT06227468 — A Clinical Study to Map the HLA Genomic Region in the Greek Population · recruiting
- NCT06347029 — Evaluation of Endothelial Dysfunction Using the "Flow Mediated Dilation" Test in a Population of Chronic Renal Failure P · NA · recruiting
- NCT05884866 — A Study to Investigate the Mechanistic Effects of Dapagliflozin Alone or in Combination With Balcinrenone, Compared to B · Phase 2 · recruiting
- NCT05353946 — Coronary Rotational Atherectomy Elective vs. Bailout in Severely Calcified Lesions and Chronic Renal Failure · NA · recruiting
Other Damanhour University trials
Trials by the same sponsor.
- NCT07307911 — Coenzyme Q10 for Neuroprotection in Paclitaxel-Induced Neuropathy · Phase 2 · completed
- NCT07341893 — Sacubitril-valsartan in Patients With Heart Failure. · NA · recruiting
- NCT07063628 — Triglyceride-Glucose Indices and Left Ventricular Speckle Tracking in Predicting Coronary Artery Disease Severity · completed
- NCT06849388 — Effect of HeartMath Intervention on Stress, Emotional Vitality and Sense of Coherence · NA · recruiting
- NCT07179302 — Pre- and Post-TAVI Patient Assessment: Advancing Outcome Precision in Aortic Valve Therapy · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03982966 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Damanhour University
- Last refreshed: 25 June 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03982966.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing